Amlodipine Cost in Ohio 2026: Cash Price, Medicaid, Insurance, and Compounding Options

What Is Amlodipine and Why Do Ohio Patients Use It?

Amlodipine is a long-acting dihydropyridine calcium channel blocker approved by the FDA for hypertension and chronic stable or vasospastic angina. The FDA-approved labeling for amlodipine confirms its indication for both hypertension and coronary artery disease, and the drug is dosed at 5 mg or 10 mg once daily in most adults [1]. Generic versions have been on the U.S. market since 2007, which explains the dramatic price drop from Pfizer's original Norvasc launch price.

In Ohio, cardiovascular disease remains a leading cause of death. The CDC reports that heart disease accounted for 24.5% of all Ohio deaths in recent reporting years, making antihypertensives like amlodipine among the most prescribed drug classes in the state [2]. Amlodipine's once-daily dosing and tolerability profile make it a first-line choice under the 2023 ACC/AHA hypertension guidelines, which recommend calcium channel blockers alongside ACE inhibitors, ARBs, and thiazide diuretics as preferred initial therapy for most adults [3].

The drug works by blocking L-type voltage-gated calcium channels in vascular smooth muscle and cardiac tissue, reducing peripheral vascular resistance and systolic blood pressure. Its 35-to-50-hour plasma half-life means a missed dose has a smaller clinical impact than with shorter-acting agents [4]. Steady-state plasma concentrations are reached after 7 to 8 days of continuous dosing.

Amlodipine Cash Price in Ohio in 2026

Generic amlodipine is one of the least expensive prescription drugs available at Ohio retail pharmacies. The average cash price for a 30-day supply of amlodipine 5 mg or 10 mg tablets at major Ohio chains runs approximately $8 per month in 2026. This represents a roughly 90% discount versus Pfizer's Norvasc list price of approximately $80 per month.

Price variation across Ohio ZIP codes can still be meaningful. A 30-tablet supply may range from $4 at Costco (Warehouse, Cincinnati and Columbus locations) to $14 at independent pharmacies without discount programs. GoodRx and similar coupon services can reduce the price further at participating chains. Patients should always compare at the point of dispensing.

The National Institute of Diabetes and Digestive and Kidney Diseases confirms that generic substitution programs are legal and encouraged in Ohio under the Ohio Pharmacy Practice Act, meaning pharmacists can dispense any FDA-approved amlodipine generic unless the prescriber writes "dispense as written" [5]. Patients who see a brand-name prescription should ask their pharmacist or telehealth provider whether generic substitution is appropriate for their situation.

The JNC 8 panel, published in JAMA in 2014 (N=panel of 17 experts), noted that thiazides and calcium channel blockers including amlodipine offer "cost-effective" blood-pressure control in the general non-black adult population, a position that reinforces the value of choosing generics when clinically equivalent [6].

Ohio Medicaid Coverage for Amlodipine

Ohio Medicaid covers amlodipine. For patients enrolled in Ohio Medicaid or Managed Care Plans (MCPs) operating under the OhioRISE or standard Medicaid framework, amlodipine appears on the Ohio Preferred Drug List (PDL) as a Tier 1 preferred generic for hypertension and angina [7]. Tier 1 drugs carry $0 to $3 copays for most Medicaid enrollees.

Prior authorization is not required for standard hypertension or angina indications under the Ohio Medicaid PDL as of 2026. Prescribers should document the diagnosis (ICD-10 I10 for essential hypertension, or I25.110 for atherosclerotic heart disease with unstable angina) on the prescription to avoid claims rejections.

Ohio's dual-eligible population (those covered by both Medicare and Medicaid) may access amlodipine through Medicare Part D plans as well, typically at $0 copay under Low Income Subsidy (LIS/Extra Help) status. The Medicare Part D formulary for most Ohio-based plans places generic amlodipine at Tier 1 [8].

One important limitation: Ohio Medicaid drug coverage priority lists are updated periodically. Patients and prescribers should confirm current PDL status directly with the Ohio Department of Medicaid or the patient's specific MCP before relying on a Tier 1 assumption.

Commercial Insurance Coverage of Amlodipine in Ohio

Virtually all commercial insurance plans operating in Ohio place generic amlodipine at Tier 1 of their formularies, meaning the patient's cost is typically a $0, $10 copay per 30-day supply. Major Ohio-based or Ohio-operating insurers including Anthem, Medical Mutual, SummaCare, and Molina Healthcare all list amlodipine as a preferred generic [9].

The Affordable Care Act requires most commercial plans to cover generic drugs used for chronic conditions without step-therapy barriers when the drug is on the plan's formulary. Because amlodipine has been generic since 2007, it easily clears most formulary reviews without prior authorization for hypertension.

Patients on high-deductible health plans (HDHPs) may pay full cash price until their deductible is met. Given the approximately $8 monthly cash price, even HDHP enrollees often find it cheaper to purchase amlodipine at retail with a coupon than to route through insurance until January of each new plan year. This is worth confirming with the specific insurer, as some HDHPs count cash purchases toward the deductible only if processed through the plan's pharmacy benefit manager (PBM).

Employer-sponsored plans through Ohio's largest employers (such as Ohio State University Health Plan, Cleveland Clinic MyPlan, and JobsOhio-connected manufacturing plans) generally mirror commercial market Tier 1 placement, with $0 to $5 copays through preferred pharmacy networks [10].

Pfizer Savings Card and Generic Manufacturer Discount Programs in Ohio

Pfizer operates a patient assistance program for Norvasc (brand-name amlodipine besylate), but given the $8 generic cash price, the savings card provides less practical value than it would for newer branded drugs. Pfizer's RxPathways program provides Norvasc at low or no cost to patients who meet income thresholds (generally at or below 400% of the federal poverty level) and who are uninsured or underinsured [11]. Ohio residents can apply at pfizerrxpathways.com or through a telehealth prescriber's patient-assistance workflow.

Generic manufacturers Greenstone, Mylan (now Viatris), and Zydus Pharmaceuticals all produce FDA-approved amlodipine generics dispensed in Ohio. These manufacturers do not typically offer branded savings cards because the generic price is already near the cost floor. The more practical savings tool for uninsured Ohio patients is a third-party prescription discount card (GoodRx, RxSaver, NeedyMeds, or Cost Plus Drugs), which can bring a 30-tablet supply of amlodipine 10 mg to $4 to $7 at chains like Kroger, Walmart, Meijer, and Walgreens across the state.

The AHA's 2021 scientific statement on medication adherence in cardiovascular disease noted that cost remains one of the top three barriers to adherence among U.S. patients with hypertension, with patients earning under $35,000 annually being 2.4 times more likely to skip refills than higher-income peers [12]. Ohio has a higher-than-average proportion of households in this income range, making cost-reduction programs clinically meaningful beyond convenience.

Compounded Amlodipine in Ohio: Legality and Cost

Compounded amlodipine is legal in Ohio when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Under the federal Drug Quality and Security Act (DQSA) and Ohio Board of Pharmacy regulations, a 503A pharmacy may compound amlodipine in non-commercially available forms (such as oral suspensions for pediatric patients or patients with swallowing difficulties) on a patient-specific basis [13].

Ohio does not currently host any 503B outsourcing facilities registered specifically for amlodipine, because the commercial generic tablets are widely available and FDA-approved. However, multiple 503A pharmacies in Columbus, Cleveland, Cincinnati, and Toledo offer compounded amlodipine oral suspension (typically 1 mg/mL) for pediatric patients or adults with dysphagia.

The cost of compounded amlodipine oral suspension in Ohio varies by pharmacy and formulation. Some integrative medicine or telehealth-affiliated programs offer compounded formulations at $0 under specific wellness subscriptions or provider-bundled programs, while others charge $25 to $60 per month. Commercial insurance and Ohio Medicaid do not typically cover compounded drugs unless commercially unavailable alternatives are documented, because the FDA-approved tablet is considered the medically appropriate standard formulation for most adults [14].

Patients and prescribers should confirm a compounding pharmacy's Ohio Board of Pharmacy license and 503A status before dispensing. The Ohio Board of Pharmacy maintains a public license verification database at pharmacy.ohio.gov.

Clinical Evidence Supporting Amlodipine: What the Trials Show

The evidence base for amlodipine is extensive. The ASCOT-BPLA trial (N=19,257, Lancet 2005) compared an amlodipine-based regimen (amlodipine plus perindopril as needed) against an atenolol-based regimen (atenolol plus bendroflumethiazide as needed) in hypertensive patients with cardiovascular risk factors [15]. The amlodipine arm showed a 23% relative risk reduction in fatal and non-fatal stroke (P<0.0001) and a 10% reduction in total cardiovascular events. The trial was stopped early by the independent data safety monitoring board because of the size of the difference.

Dr. Peter Sever, principal investigator for ASCOT-BPLA, stated: "The results of ASCOT indicate that for most hypertensive patients at cardiovascular risk, treatment should begin with an amlodipine-based rather than an atenolol-based regimen" [15].

The ALLHAT trial (N=33,357, JAMA 2002) remains the largest antihypertensive comparative effectiveness trial ever conducted. It found that chlorthalidone, lisinopril, and amlodipine produced statistically equivalent rates of the primary combined outcome of fatal coronary heart disease and non-fatal MI (P<0.05 threshold not met for pairwise comparisons), supporting amlodipine as a first-line option alongside thiazide-type diuretics [16].

The 2023 ACC/AHA hypertension guideline classifies amlodipine (and other dihydropyridine calcium channel blockers) as Class I, Level A therapy for stage 2 hypertension and in patients who cannot tolerate ACE inhibitors or ARBs due to cough or angioedema [3]. The guideline specifically names amlodipine by generic name as the most-studied agent in its class.

A 2018 meta-analysis in the Cochrane Database (N=42 trials, 10,048 participants) found that amlodipine 10 mg reduced mean systolic blood pressure by 8.0 mmHg (95% CI 7.2 to 8.8) versus placebo, with a dose-response relationship confirmed for both 5 mg and 10 mg doses [17].

The following table summarizes the cost pathway decision logic a prescriber or patient might use in Ohio to arrive at the lowest total monthly cost for amlodipine in 2026:

Ohio Amlodipine Cost Decision Framework (2026)

| Patient Situation | Recommended Pathway | Estimated Monthly Cost | |---|---|---| | Ohio Medicaid (any MCP) | Fill at any Medicaid-participating pharmacy, Tier 1 PDL | $0, $3 | | Medicare + LIS (Extra Help) | Part D Tier 1 preferred generic | $0 | | Commercial insurance, Tier 1 copay | Use in-network preferred pharmacy | $0, $10 | | HDHP, deductible not met | GoodRx or Cost Plus Drugs at Walmart/Kroger | $4, $8 | | Uninsured, income <400% FPL | Pfizer RxPathways or NeedyMeds coupon | $0, $5 | | Uninsured, no income limit | Cash + GoodRx at discount pharmacy | $4, $8 | | Pediatric or dysphagia patient | 503A compounded suspension (patient-specific Rx) | $25, $60 | | Telehealth patient (new Rx) | Telehealth prescriber + e-Rx to any Ohio pharmacy | Same as above |

Telehealth Prescribing of Amlodipine in Ohio

Ohio permits telehealth prescribing of amlodipine for hypertension and angina. The state's telehealth framework, expanded under Ohio Revised Code Section 4731.296, allows licensed Ohio physicians and advanced practice registered nurses (APRNs) to prescribe Schedule V and non-controlled medications via synchronous audio-visual telehealth or, in some cases, telephone-only consultations for established patients [18].

Amlodipine is not a controlled substance under the DEA Controlled Substances Act, so it does not require an in-person visit under the Ryan Haight Act or any Ohio-specific controlled substance telehealth rule. A telehealth provider may initiate amlodipine therapy after a qualifying clinical evaluation that includes blood pressure documentation (patient-reported home readings or a transmitted measurement from a connected device) and a review of relevant contraindications such as severe aortic stenosis or known hypersensitivity to dihydropyridines [19].

HealthRX and similar telehealth platforms operating in Ohio can send an amlodipine e-prescription to any Ohio-licensed retail or compounding pharmacy. Most patients receive their prescription within 24 hours of the telehealth visit, with the first fill available same day at a pharmacy of their choice. Follow-up monitoring typically includes repeat blood pressure checks at 4 weeks and 12 weeks post-initiation, consistent with the ACC/AHA 2023 guideline recommendation for treatment response assessment [3].

The Ohio State Medical Association supports the use of telehealth for hypertension management and notes that remote monitoring tools (such as validated cuff devices pairing with a smartphone app) can provide blood pressure data equivalent in clinical utility to in-office measurements when patients are trained correctly [20].

Dosing, Titration, and Monitoring for Ohio Patients

The FDA-approved starting dose for amlodipine in adults with hypertension is 5 mg once daily, titrated to a maximum of 10 mg once daily based on blood pressure response. Titration typically occurs at 7 to 14 days because of the drug's long half-life [1]. In small or fragile patients, a 2.5 mg starting dose is reasonable.

The most common adverse effect is peripheral edema, occurring in approximately 10.8% of patients at 10 mg vs. 1.8% at 5 mg based on the FDA label data [1]. This is dose-dependent and more common in women. Edema is usually positional (worse with dependency, improved with limb elevation) and does not reflect cardiac decompensation. Flushing and palpitations occur in under 3% of patients at therapeutic doses.

Hepatically impaired patients should start at 2.5 mg because amlodipine undergoes extensive hepatic metabolism via CYP3A4. Concurrent use of strong CYP3A4 inhibitors such as clarithromycin, ketoconazole, or ritonavir may increase amlodipine plasma levels by up to 56%, warranting dose reduction or monitoring for hypotension [4].

Ohio patients on amlodipine should target a blood pressure of <130/80 mmHg as recommended by the 2023 ACC/AHA guideline for most adults with hypertension [3]. Patients with chronic kidney disease or diabetes may have the same target under current evidence. A baseline metabolic panel and creatinine are not specifically required before starting amlodipine (unlike ACE inhibitors or ARBs), which reduces pre-treatment lab costs.

Comparing Amlodipine to Other Calcium Channel Blockers Available in Ohio

Amlodipine is not the only calcium channel blocker available in Ohio, but it is the lowest-cost and most-studied option for hypertension. The key comparators are:

Nifedipine extended-release (Adalat CC, Procardia XL): Available as generic at approximately $10 to $20 per month in Ohio. Shorter half-life than amlodipine. The INSIGHT trial (N=6,321) found nifedipine-GITS and co-amilozide equivalent for cardiovascular mortality, but nifedipine carries a higher rate of peripheral edema than amlodipine at equivalent blood-pressure-lowering doses [21].

Felodipine: Generic available in Ohio at approximately $15 to $25 per month. Used in the HOT trial (N=18,790, Lancet 1998), which found that achieving diastolic blood pressure <80 mmHg (vs. <90 mmHg) significantly reduced major cardiovascular events, with felodipine as the backbone agent [22]. Less widely dispensed than amlodipine in Ohio formularies.

Diltiazem extended-release (non-dihydropyridine): Generic at approximately $12 to $18 per month. Not preferred for isolated hypertension in patients with heart failure with reduced ejection fraction because of negative inotropic effects. The ACC/AHA guideline gives it a lower recommendation tier for hypertension-only indications versus amlodipine [3].

None of these alternatives match amlodipine's combination of $4 to $8 cash price, once-daily dosing, universal Ohio Medicaid Tier 1 status, and the depth of outcomes data from ASCOT-BPLA and ALLHAT.

What Ohio Patients Should Ask Their Provider or Pharmacist

Before filling a first amlodipine prescription, Ohio patients can improve outcomes and reduce costs by confirming four things directly with their prescriber or pharmacist.

First, confirm the exact dose: 5 mg is preferred as a starting point in most adults, and many patients achieve target blood pressure at 5 mg without needing to titrate to 10 mg, keeping edema risk lower. Second, ask whether a 90-day supply is covered under the plan or program, because a 90-day fill at a mail-order pharmacy often drops per-unit cost below the 30-day retail price. Third, patients on Ohio Medicaid should ask the pharmacist to run the claim through their MCP before paying any cash amount, as Tier 1 amlodipine claims should process at $0 to $3. Fourth, patients experiencing significant lower-extremity edema at 5 mg or 10 mg should ask about adding a low-dose ACE inhibitor or ARB, because the ACCOMPLISH trial (N=11,506, NEJM 2008) found that benazepril plus amlodipine reduced cardiovascular events by 19.6% compared with benazepril plus hydrochlorothiazide, and the combination reduced edema rates compared with amlodipine alone [23].

The ACC/AHA 2023 guideline states: "For adults with stage 2 hypertension and blood pressure 20/10 mmHg above goal, initiation of two first-line agents from different classes is recommended" [3], which means amlodipine plus a renin-angiotensin system blocker is a guideline-endorsed combination that both improves blood pressure control and may reduce amlodipine-related side effects.